Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes

Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug–gene (pharmacogenetic), drug–drug ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacogenomics 2021-07, Vol.22 (10), p.603-618
Hauptverfasser: Sahana, S, Sivadas, Ambily, Mangla, Mohit, Jain, Abhinav, Bhoyar, Rahul C, Pandhare, Kavita, Mishra, Anushree, Sharma, Disha, Imran, Mohamed, Senthivel, Vigneshwar, Divakar, Mohit Kumar, Rophina, Mercy, Jolly, Bani, Batra, Arushi, Sharma, Sumit, Siwach, Sanjay, Jadhao, Arun G, Palande, Nikhil V, Jha, Ganga Nath, Ashrafi, Nishat, Mishra, Prashant Kumar, Vidhya, AK, Jain, Suman, Dash, Debasis, Kumar, Nachimuthu Senthil, Vanlallawma, Andrew, Sarma, Ranjan Jyoti, Chhakchhuak, Lalchhandama, Kalyanaraman, Shantaraman, Mahadevan, Radha, Kandasamy, Sunitha, Devi, Pabitha, Rajagopal, Raskin Erusan, Ramya, J Ezhil, Devi, P Nirmala, Bajaj, Anjali, Gupta, Vishu, Mathew, Samatha, Goswami, Sangam, Prakash, Savinitha, Joshi, Kandarp, Kumla, Meya, Sreedevi, S, Gajjar, Devarshi, Soraisham, Ronibala, Yadav, Rohit, Devi, Yumnam Silla, Gupta, Aayush, Mukerji, Mitali, Ramalingam, Sivaprakash, Binukumar, BK, Sivasubbu, Sridhar, Scaria, Vinod
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 618
container_issue 10
container_start_page 603
container_title Pharmacogenomics
container_volume 22
creator Sahana, S
Sivadas, Ambily
Mangla, Mohit
Jain, Abhinav
Bhoyar, Rahul C
Pandhare, Kavita
Mishra, Anushree
Sharma, Disha
Imran, Mohamed
Senthivel, Vigneshwar
Divakar, Mohit Kumar
Rophina, Mercy
Jolly, Bani
Batra, Arushi
Sharma, Sumit
Siwach, Sanjay
Jadhao, Arun G
Palande, Nikhil V
Jha, Ganga Nath
Ashrafi, Nishat
Mishra, Prashant Kumar
Vidhya, AK
Jain, Suman
Dash, Debasis
Kumar, Nachimuthu Senthil
Vanlallawma, Andrew
Sarma, Ranjan Jyoti
Chhakchhuak, Lalchhandama
Kalyanaraman, Shantaraman
Mahadevan, Radha
Kandasamy, Sunitha
Devi, Pabitha
Rajagopal, Raskin Erusan
Ramya, J Ezhil
Devi, P Nirmala
Bajaj, Anjali
Gupta, Vishu
Mathew, Samatha
Goswami, Sangam
Prakash, Savinitha
Joshi, Kandarp
Kumla, Meya
Sreedevi, S
Gajjar, Devarshi
Soraisham, Ronibala
Yadav, Rohit
Devi, Yumnam Silla
Gupta, Aayush
Mukerji, Mitali
Ramalingam, Sivaprakash
Binukumar, BK
Sivasubbu, Sridhar
Scaria, Vinod
description Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug–gene (pharmacogenetic), drug–drug and drug–drug–gene interactions associated with COVID-19 therapy in the Indian population. We identified 30 clinically significant pharmacogenetic variants and 73 predicted deleterious pharmacogenetic variants. COVID-19-associated pharmacogenes were substantially overlapped with those of metabolic disorder therapeutics. , and are the most shared pharmacogenes. Fifteen COVID-19 therapeutics were predicted as likely drug–drug interaction candidates when used with four inhibitor drugs. Our findings provide actionable insights for future validation studies and improved clinical decisions for COVID-19 therapy in Indians.
doi_str_mv 10.2217/pgs-2021-0028
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8216321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8216321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-581fdbf405b6b9d5cf48dc34471283bc20aa79022595b215a44758bc02af7fc33</originalsourceid><addsrcrecordid>eNp1kEtLxDAQx4Morq4evfcLRJNp0sdFkPW1sLge1GtI02Q30iYlaQW_vVlXBA-eZob5P-CH0AUllwC0vBo2EQMBigmB6gCd0JIxXBEGh2lnBWBgtJih0xjfk4IWjByjWc4oA16QE_T0vJWhl8pvtPO9VVknXRuVHHTmTbZYvy1vMa2zcauDHKyOmQm-z5autdJlgx-mTo7Wu-zbruMZOjKyi_r8Z87R6_3dy-IRr9YPy8XNCqvUPGJeUdM2hhHeFE3dcmVY1aqcsZJClTcKiJRlTQB4zRugXKYPrxpFQJrSqDyfo-t97jA1vW6VdmOQnRiC7WX4FF5a8ffj7FZs_IeoEoIcaArA-wAVfIxBm18vJWIHViSwYgdW7MAmfb3Xm2mcgo7Kaqe02F-pxyrr9D_eL-ozfts</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes</title><source>PubMed Central</source><creator>Sahana, S ; Sivadas, Ambily ; Mangla, Mohit ; Jain, Abhinav ; Bhoyar, Rahul C ; Pandhare, Kavita ; Mishra, Anushree ; Sharma, Disha ; Imran, Mohamed ; Senthivel, Vigneshwar ; Divakar, Mohit Kumar ; Rophina, Mercy ; Jolly, Bani ; Batra, Arushi ; Sharma, Sumit ; Siwach, Sanjay ; Jadhao, Arun G ; Palande, Nikhil V ; Jha, Ganga Nath ; Ashrafi, Nishat ; Mishra, Prashant Kumar ; Vidhya, AK ; Jain, Suman ; Dash, Debasis ; Kumar, Nachimuthu Senthil ; Vanlallawma, Andrew ; Sarma, Ranjan Jyoti ; Chhakchhuak, Lalchhandama ; Kalyanaraman, Shantaraman ; Mahadevan, Radha ; Kandasamy, Sunitha ; Devi, Pabitha ; Rajagopal, Raskin Erusan ; Ramya, J Ezhil ; Devi, P Nirmala ; Bajaj, Anjali ; Gupta, Vishu ; Mathew, Samatha ; Goswami, Sangam ; Prakash, Savinitha ; Joshi, Kandarp ; Kumla, Meya ; Sreedevi, S ; Gajjar, Devarshi ; Soraisham, Ronibala ; Yadav, Rohit ; Devi, Yumnam Silla ; Gupta, Aayush ; Mukerji, Mitali ; Ramalingam, Sivaprakash ; Binukumar, BK ; Sivasubbu, Sridhar ; Scaria, Vinod</creator><creatorcontrib>Sahana, S ; Sivadas, Ambily ; Mangla, Mohit ; Jain, Abhinav ; Bhoyar, Rahul C ; Pandhare, Kavita ; Mishra, Anushree ; Sharma, Disha ; Imran, Mohamed ; Senthivel, Vigneshwar ; Divakar, Mohit Kumar ; Rophina, Mercy ; Jolly, Bani ; Batra, Arushi ; Sharma, Sumit ; Siwach, Sanjay ; Jadhao, Arun G ; Palande, Nikhil V ; Jha, Ganga Nath ; Ashrafi, Nishat ; Mishra, Prashant Kumar ; Vidhya, AK ; Jain, Suman ; Dash, Debasis ; Kumar, Nachimuthu Senthil ; Vanlallawma, Andrew ; Sarma, Ranjan Jyoti ; Chhakchhuak, Lalchhandama ; Kalyanaraman, Shantaraman ; Mahadevan, Radha ; Kandasamy, Sunitha ; Devi, Pabitha ; Rajagopal, Raskin Erusan ; Ramya, J Ezhil ; Devi, P Nirmala ; Bajaj, Anjali ; Gupta, Vishu ; Mathew, Samatha ; Goswami, Sangam ; Prakash, Savinitha ; Joshi, Kandarp ; Kumla, Meya ; Sreedevi, S ; Gajjar, Devarshi ; Soraisham, Ronibala ; Yadav, Rohit ; Devi, Yumnam Silla ; Gupta, Aayush ; Mukerji, Mitali ; Ramalingam, Sivaprakash ; Binukumar, BK ; Sivasubbu, Sridhar ; Scaria, Vinod</creatorcontrib><description>Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug–gene (pharmacogenetic), drug–drug and drug–drug–gene interactions associated with COVID-19 therapy in the Indian population. We identified 30 clinically significant pharmacogenetic variants and 73 predicted deleterious pharmacogenetic variants. COVID-19-associated pharmacogenes were substantially overlapped with those of metabolic disorder therapeutics. , and are the most shared pharmacogenes. Fifteen COVID-19 therapeutics were predicted as likely drug–drug interaction candidates when used with four inhibitor drugs. Our findings provide actionable insights for future validation studies and improved clinical decisions for COVID-19 therapy in Indians.</description><identifier>ISSN: 1462-2416</identifier><identifier>EISSN: 1744-8042</identifier><identifier>DOI: 10.2217/pgs-2021-0028</identifier><identifier>PMID: 34142560</identifier><language>eng</language><publisher>London, UK: Future Medicine Ltd</publisher><subject>COVID-19 therapies ; drug–drug interactions ; drug–drug–gene interactions ; Indian population ; pharmacogenomics</subject><ispartof>Pharmacogenomics, 2021-07, Vol.22 (10), p.603-618</ispartof><rights>2021 Future Medicine Ltd</rights><rights>2021 Future Medicine Ltd 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-581fdbf405b6b9d5cf48dc34471283bc20aa79022595b215a44758bc02af7fc33</citedby><cites>FETCH-LOGICAL-c414t-581fdbf405b6b9d5cf48dc34471283bc20aa79022595b215a44758bc02af7fc33</cites><orcidid>0000-0003-1267-3803</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216321/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216321/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Sahana, S</creatorcontrib><creatorcontrib>Sivadas, Ambily</creatorcontrib><creatorcontrib>Mangla, Mohit</creatorcontrib><creatorcontrib>Jain, Abhinav</creatorcontrib><creatorcontrib>Bhoyar, Rahul C</creatorcontrib><creatorcontrib>Pandhare, Kavita</creatorcontrib><creatorcontrib>Mishra, Anushree</creatorcontrib><creatorcontrib>Sharma, Disha</creatorcontrib><creatorcontrib>Imran, Mohamed</creatorcontrib><creatorcontrib>Senthivel, Vigneshwar</creatorcontrib><creatorcontrib>Divakar, Mohit Kumar</creatorcontrib><creatorcontrib>Rophina, Mercy</creatorcontrib><creatorcontrib>Jolly, Bani</creatorcontrib><creatorcontrib>Batra, Arushi</creatorcontrib><creatorcontrib>Sharma, Sumit</creatorcontrib><creatorcontrib>Siwach, Sanjay</creatorcontrib><creatorcontrib>Jadhao, Arun G</creatorcontrib><creatorcontrib>Palande, Nikhil V</creatorcontrib><creatorcontrib>Jha, Ganga Nath</creatorcontrib><creatorcontrib>Ashrafi, Nishat</creatorcontrib><creatorcontrib>Mishra, Prashant Kumar</creatorcontrib><creatorcontrib>Vidhya, AK</creatorcontrib><creatorcontrib>Jain, Suman</creatorcontrib><creatorcontrib>Dash, Debasis</creatorcontrib><creatorcontrib>Kumar, Nachimuthu Senthil</creatorcontrib><creatorcontrib>Vanlallawma, Andrew</creatorcontrib><creatorcontrib>Sarma, Ranjan Jyoti</creatorcontrib><creatorcontrib>Chhakchhuak, Lalchhandama</creatorcontrib><creatorcontrib>Kalyanaraman, Shantaraman</creatorcontrib><creatorcontrib>Mahadevan, Radha</creatorcontrib><creatorcontrib>Kandasamy, Sunitha</creatorcontrib><creatorcontrib>Devi, Pabitha</creatorcontrib><creatorcontrib>Rajagopal, Raskin Erusan</creatorcontrib><creatorcontrib>Ramya, J Ezhil</creatorcontrib><creatorcontrib>Devi, P Nirmala</creatorcontrib><creatorcontrib>Bajaj, Anjali</creatorcontrib><creatorcontrib>Gupta, Vishu</creatorcontrib><creatorcontrib>Mathew, Samatha</creatorcontrib><creatorcontrib>Goswami, Sangam</creatorcontrib><creatorcontrib>Prakash, Savinitha</creatorcontrib><creatorcontrib>Joshi, Kandarp</creatorcontrib><creatorcontrib>Kumla, Meya</creatorcontrib><creatorcontrib>Sreedevi, S</creatorcontrib><creatorcontrib>Gajjar, Devarshi</creatorcontrib><creatorcontrib>Soraisham, Ronibala</creatorcontrib><creatorcontrib>Yadav, Rohit</creatorcontrib><creatorcontrib>Devi, Yumnam Silla</creatorcontrib><creatorcontrib>Gupta, Aayush</creatorcontrib><creatorcontrib>Mukerji, Mitali</creatorcontrib><creatorcontrib>Ramalingam, Sivaprakash</creatorcontrib><creatorcontrib>Binukumar, BK</creatorcontrib><creatorcontrib>Sivasubbu, Sridhar</creatorcontrib><creatorcontrib>Scaria, Vinod</creatorcontrib><title>Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes</title><title>Pharmacogenomics</title><description>Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug–gene (pharmacogenetic), drug–drug and drug–drug–gene interactions associated with COVID-19 therapy in the Indian population. We identified 30 clinically significant pharmacogenetic variants and 73 predicted deleterious pharmacogenetic variants. COVID-19-associated pharmacogenes were substantially overlapped with those of metabolic disorder therapeutics. , and are the most shared pharmacogenes. Fifteen COVID-19 therapeutics were predicted as likely drug–drug interaction candidates when used with four inhibitor drugs. Our findings provide actionable insights for future validation studies and improved clinical decisions for COVID-19 therapy in Indians.</description><subject>COVID-19 therapies</subject><subject>drug–drug interactions</subject><subject>drug–drug–gene interactions</subject><subject>Indian population</subject><subject>pharmacogenomics</subject><issn>1462-2416</issn><issn>1744-8042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLxDAQx4Morq4evfcLRJNp0sdFkPW1sLge1GtI02Q30iYlaQW_vVlXBA-eZob5P-CH0AUllwC0vBo2EQMBigmB6gCd0JIxXBEGh2lnBWBgtJih0xjfk4IWjByjWc4oA16QE_T0vJWhl8pvtPO9VVknXRuVHHTmTbZYvy1vMa2zcauDHKyOmQm-z5autdJlgx-mTo7Wu-zbruMZOjKyi_r8Z87R6_3dy-IRr9YPy8XNCqvUPGJeUdM2hhHeFE3dcmVY1aqcsZJClTcKiJRlTQB4zRugXKYPrxpFQJrSqDyfo-t97jA1vW6VdmOQnRiC7WX4FF5a8ffj7FZs_IeoEoIcaArA-wAVfIxBm18vJWIHViSwYgdW7MAmfb3Xm2mcgo7Kaqe02F-pxyrr9D_eL-ozfts</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Sahana, S</creator><creator>Sivadas, Ambily</creator><creator>Mangla, Mohit</creator><creator>Jain, Abhinav</creator><creator>Bhoyar, Rahul C</creator><creator>Pandhare, Kavita</creator><creator>Mishra, Anushree</creator><creator>Sharma, Disha</creator><creator>Imran, Mohamed</creator><creator>Senthivel, Vigneshwar</creator><creator>Divakar, Mohit Kumar</creator><creator>Rophina, Mercy</creator><creator>Jolly, Bani</creator><creator>Batra, Arushi</creator><creator>Sharma, Sumit</creator><creator>Siwach, Sanjay</creator><creator>Jadhao, Arun G</creator><creator>Palande, Nikhil V</creator><creator>Jha, Ganga Nath</creator><creator>Ashrafi, Nishat</creator><creator>Mishra, Prashant Kumar</creator><creator>Vidhya, AK</creator><creator>Jain, Suman</creator><creator>Dash, Debasis</creator><creator>Kumar, Nachimuthu Senthil</creator><creator>Vanlallawma, Andrew</creator><creator>Sarma, Ranjan Jyoti</creator><creator>Chhakchhuak, Lalchhandama</creator><creator>Kalyanaraman, Shantaraman</creator><creator>Mahadevan, Radha</creator><creator>Kandasamy, Sunitha</creator><creator>Devi, Pabitha</creator><creator>Rajagopal, Raskin Erusan</creator><creator>Ramya, J Ezhil</creator><creator>Devi, P Nirmala</creator><creator>Bajaj, Anjali</creator><creator>Gupta, Vishu</creator><creator>Mathew, Samatha</creator><creator>Goswami, Sangam</creator><creator>Prakash, Savinitha</creator><creator>Joshi, Kandarp</creator><creator>Kumla, Meya</creator><creator>Sreedevi, S</creator><creator>Gajjar, Devarshi</creator><creator>Soraisham, Ronibala</creator><creator>Yadav, Rohit</creator><creator>Devi, Yumnam Silla</creator><creator>Gupta, Aayush</creator><creator>Mukerji, Mitali</creator><creator>Ramalingam, Sivaprakash</creator><creator>Binukumar, BK</creator><creator>Sivasubbu, Sridhar</creator><creator>Scaria, Vinod</creator><general>Future Medicine Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1267-3803</orcidid></search><sort><creationdate>20210701</creationdate><title>Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes</title><author>Sahana, S ; Sivadas, Ambily ; Mangla, Mohit ; Jain, Abhinav ; Bhoyar, Rahul C ; Pandhare, Kavita ; Mishra, Anushree ; Sharma, Disha ; Imran, Mohamed ; Senthivel, Vigneshwar ; Divakar, Mohit Kumar ; Rophina, Mercy ; Jolly, Bani ; Batra, Arushi ; Sharma, Sumit ; Siwach, Sanjay ; Jadhao, Arun G ; Palande, Nikhil V ; Jha, Ganga Nath ; Ashrafi, Nishat ; Mishra, Prashant Kumar ; Vidhya, AK ; Jain, Suman ; Dash, Debasis ; Kumar, Nachimuthu Senthil ; Vanlallawma, Andrew ; Sarma, Ranjan Jyoti ; Chhakchhuak, Lalchhandama ; Kalyanaraman, Shantaraman ; Mahadevan, Radha ; Kandasamy, Sunitha ; Devi, Pabitha ; Rajagopal, Raskin Erusan ; Ramya, J Ezhil ; Devi, P Nirmala ; Bajaj, Anjali ; Gupta, Vishu ; Mathew, Samatha ; Goswami, Sangam ; Prakash, Savinitha ; Joshi, Kandarp ; Kumla, Meya ; Sreedevi, S ; Gajjar, Devarshi ; Soraisham, Ronibala ; Yadav, Rohit ; Devi, Yumnam Silla ; Gupta, Aayush ; Mukerji, Mitali ; Ramalingam, Sivaprakash ; Binukumar, BK ; Sivasubbu, Sridhar ; Scaria, Vinod</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-581fdbf405b6b9d5cf48dc34471283bc20aa79022595b215a44758bc02af7fc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19 therapies</topic><topic>drug–drug interactions</topic><topic>drug–drug–gene interactions</topic><topic>Indian population</topic><topic>pharmacogenomics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sahana, S</creatorcontrib><creatorcontrib>Sivadas, Ambily</creatorcontrib><creatorcontrib>Mangla, Mohit</creatorcontrib><creatorcontrib>Jain, Abhinav</creatorcontrib><creatorcontrib>Bhoyar, Rahul C</creatorcontrib><creatorcontrib>Pandhare, Kavita</creatorcontrib><creatorcontrib>Mishra, Anushree</creatorcontrib><creatorcontrib>Sharma, Disha</creatorcontrib><creatorcontrib>Imran, Mohamed</creatorcontrib><creatorcontrib>Senthivel, Vigneshwar</creatorcontrib><creatorcontrib>Divakar, Mohit Kumar</creatorcontrib><creatorcontrib>Rophina, Mercy</creatorcontrib><creatorcontrib>Jolly, Bani</creatorcontrib><creatorcontrib>Batra, Arushi</creatorcontrib><creatorcontrib>Sharma, Sumit</creatorcontrib><creatorcontrib>Siwach, Sanjay</creatorcontrib><creatorcontrib>Jadhao, Arun G</creatorcontrib><creatorcontrib>Palande, Nikhil V</creatorcontrib><creatorcontrib>Jha, Ganga Nath</creatorcontrib><creatorcontrib>Ashrafi, Nishat</creatorcontrib><creatorcontrib>Mishra, Prashant Kumar</creatorcontrib><creatorcontrib>Vidhya, AK</creatorcontrib><creatorcontrib>Jain, Suman</creatorcontrib><creatorcontrib>Dash, Debasis</creatorcontrib><creatorcontrib>Kumar, Nachimuthu Senthil</creatorcontrib><creatorcontrib>Vanlallawma, Andrew</creatorcontrib><creatorcontrib>Sarma, Ranjan Jyoti</creatorcontrib><creatorcontrib>Chhakchhuak, Lalchhandama</creatorcontrib><creatorcontrib>Kalyanaraman, Shantaraman</creatorcontrib><creatorcontrib>Mahadevan, Radha</creatorcontrib><creatorcontrib>Kandasamy, Sunitha</creatorcontrib><creatorcontrib>Devi, Pabitha</creatorcontrib><creatorcontrib>Rajagopal, Raskin Erusan</creatorcontrib><creatorcontrib>Ramya, J Ezhil</creatorcontrib><creatorcontrib>Devi, P Nirmala</creatorcontrib><creatorcontrib>Bajaj, Anjali</creatorcontrib><creatorcontrib>Gupta, Vishu</creatorcontrib><creatorcontrib>Mathew, Samatha</creatorcontrib><creatorcontrib>Goswami, Sangam</creatorcontrib><creatorcontrib>Prakash, Savinitha</creatorcontrib><creatorcontrib>Joshi, Kandarp</creatorcontrib><creatorcontrib>Kumla, Meya</creatorcontrib><creatorcontrib>Sreedevi, S</creatorcontrib><creatorcontrib>Gajjar, Devarshi</creatorcontrib><creatorcontrib>Soraisham, Ronibala</creatorcontrib><creatorcontrib>Yadav, Rohit</creatorcontrib><creatorcontrib>Devi, Yumnam Silla</creatorcontrib><creatorcontrib>Gupta, Aayush</creatorcontrib><creatorcontrib>Mukerji, Mitali</creatorcontrib><creatorcontrib>Ramalingam, Sivaprakash</creatorcontrib><creatorcontrib>Binukumar, BK</creatorcontrib><creatorcontrib>Sivasubbu, Sridhar</creatorcontrib><creatorcontrib>Scaria, Vinod</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacogenomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sahana, S</au><au>Sivadas, Ambily</au><au>Mangla, Mohit</au><au>Jain, Abhinav</au><au>Bhoyar, Rahul C</au><au>Pandhare, Kavita</au><au>Mishra, Anushree</au><au>Sharma, Disha</au><au>Imran, Mohamed</au><au>Senthivel, Vigneshwar</au><au>Divakar, Mohit Kumar</au><au>Rophina, Mercy</au><au>Jolly, Bani</au><au>Batra, Arushi</au><au>Sharma, Sumit</au><au>Siwach, Sanjay</au><au>Jadhao, Arun G</au><au>Palande, Nikhil V</au><au>Jha, Ganga Nath</au><au>Ashrafi, Nishat</au><au>Mishra, Prashant Kumar</au><au>Vidhya, AK</au><au>Jain, Suman</au><au>Dash, Debasis</au><au>Kumar, Nachimuthu Senthil</au><au>Vanlallawma, Andrew</au><au>Sarma, Ranjan Jyoti</au><au>Chhakchhuak, Lalchhandama</au><au>Kalyanaraman, Shantaraman</au><au>Mahadevan, Radha</au><au>Kandasamy, Sunitha</au><au>Devi, Pabitha</au><au>Rajagopal, Raskin Erusan</au><au>Ramya, J Ezhil</au><au>Devi, P Nirmala</au><au>Bajaj, Anjali</au><au>Gupta, Vishu</au><au>Mathew, Samatha</au><au>Goswami, Sangam</au><au>Prakash, Savinitha</au><au>Joshi, Kandarp</au><au>Kumla, Meya</au><au>Sreedevi, S</au><au>Gajjar, Devarshi</au><au>Soraisham, Ronibala</au><au>Yadav, Rohit</au><au>Devi, Yumnam Silla</au><au>Gupta, Aayush</au><au>Mukerji, Mitali</au><au>Ramalingam, Sivaprakash</au><au>Binukumar, BK</au><au>Sivasubbu, Sridhar</au><au>Scaria, Vinod</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes</atitle><jtitle>Pharmacogenomics</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>22</volume><issue>10</issue><spage>603</spage><epage>618</epage><pages>603-618</pages><issn>1462-2416</issn><eissn>1744-8042</eissn><abstract>Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug–gene (pharmacogenetic), drug–drug and drug–drug–gene interactions associated with COVID-19 therapy in the Indian population. We identified 30 clinically significant pharmacogenetic variants and 73 predicted deleterious pharmacogenetic variants. COVID-19-associated pharmacogenes were substantially overlapped with those of metabolic disorder therapeutics. , and are the most shared pharmacogenes. Fifteen COVID-19 therapeutics were predicted as likely drug–drug interaction candidates when used with four inhibitor drugs. Our findings provide actionable insights for future validation studies and improved clinical decisions for COVID-19 therapy in Indians.</abstract><cop>London, UK</cop><pub>Future Medicine Ltd</pub><pmid>34142560</pmid><doi>10.2217/pgs-2021-0028</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-1267-3803</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-2416
ispartof Pharmacogenomics, 2021-07, Vol.22 (10), p.603-618
issn 1462-2416
1744-8042
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8216321
source PubMed Central
subjects COVID-19 therapies
drug–drug interactions
drug–drug–gene interactions
Indian population
pharmacogenomics
title Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A26%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenomic%20landscape%20of%20COVID-19%20therapies%20from%20Indian%20population%20genomes&rft.jtitle=Pharmacogenomics&rft.au=Sahana,%20S&rft.date=2021-07-01&rft.volume=22&rft.issue=10&rft.spage=603&rft.epage=618&rft.pages=603-618&rft.issn=1462-2416&rft.eissn=1744-8042&rft_id=info:doi/10.2217/pgs-2021-0028&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8216321%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34142560&rfr_iscdi=true